Back to search

Biosite Systems Limited

07308880

active
Private Limited Company
england wales
Companies House
Health Score
75 / 100

Some Concerns

25/30
Filing
10/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)

Details

UNIT 5 CRANBROOK WAY, SOLIHULL, B90 4GT
Incorporated 08/07/2010

Compliance

Last accounts

31/12/2024

full

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 10/02/2026

Due 24/02/2027

On track

Industry

26309
26309
62012
Business and domestic software development
72190
Other research and experimental development on natural sciences and engineering
80200
Security systems service activities

Officers

Richard Melvyn Eastburn

director · Since 17/03/2025

British

Claire Sally Leighton

director · Since 28/01/2022

British

Steven Robert Reid

director · Since 28/01/2022

British

Former

Heidi Wang

secretary · Resigned 07/02/2020

Samuel Erik Johannes Asarnoj

director · Resigned 23/12/2021

Abhir Hari Bhalerao

director · Resigned 11/11/2016

Michael Thomas Bryant

director · Resigned 31/03/2025

Michael Thomas Bryant

director · Resigned 07/02/2020

Douglas Ferry

director · Resigned 07/02/2020

Gregory Michael Reynolds

director · Resigned 07/02/2020

Michael Charles Rimmington

director · Resigned 30/06/2023

Michael Charles Rimmington

director · Resigned 05/06/2023

Michael Charles Rimmington

director · Resigned 07/02/2020

Matthew John Sadler

director · Resigned 24/06/2019

Christophe Philippe Sut

director · Resigned 30/09/2021

Catharina Eva Tunberg

director · Resigned 21/01/2022

Li Wang

director · Resigned 20/02/2022

Ederyn Williams

director · Resigned 07/02/2020

CompanyRankvs 105+ SIC 26309 peers
79

Financial strength96th percentile among SIC peers · 24/25
Employees100th percentile among SIC peers · 15/15
LiquidityCurrent ratio 2.32× · 20/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

to evaluate the directors’ assessment of the company’s ability to continue to adopt the going concern basis of accounting included but were not limited to: • Undertaking an initial assessment at the planning stage of the audit to identify events or conditions that may cast significant doubt on the co

Key FinancialsYear ending 31/12/2022

Turnover

£23.2M

Annual revenue

Net Worth

£6.7M

Balance sheet strength

Cash

Cash in the bank

Profit Before Tax

£3.0M

Bottom line earnings

Net Current Assets

£6.0M

Working capital

Current Assets

£10.6M

Current Liabilities

£4.6M

Fixed Assets

£675k

Debtors

£6.9M

Cost of Sales

£7.3M

Gross Profit

£15.9M

Admin Expenses

£14.0M

Operating Profit

£3.0M

Profit After Tax

£2.6M

168avg. employees

Tax at Year End

Corp tax£325k

People Costs

Wages & salaries£8.3M
NI contributions£1.1M

Balance Sheet

Assets less current liabilities£6.7M
Prepared with Caseware UK (AP4) 2022.0.179

EstimatesDerived

YearCurrent Ratio
20222.32

Derived from filed accounts. Not audited figures.